Lipoprotein profiles in human heterozygote carriers of a functional mutation P297S in scavenger receptor class B1.
Stefan A Ljunggren, Johannes H M Levels, Kees Hovingh, Adriaan G Holleboom, Menno Vergeer, Letta Argyri, Christina Gkolfinopoulou, Angeliki Chroni, Jeroen A Sierts, John J Kastelein, Jan Albert Kuivenhoven, Mats Lindahl, Helen Karlsson
Index: Biochim. Biophys. Acta 1851 , 1587-95, (2015)
Full Text: HTML
Abstract
The scavenger receptor class B type 1 (SR-B1) is an important HDL receptor involved in cholesterol uptake and efflux, but its physiological role in human lipoprotein metabolism is not fully understood. Heterozygous carriers of the SR-B1(P297S) mutation are characterized by increased HDL cholesterol levels, impaired cholesterol efflux from macrophages and attenuated adrenal function. Here, the composition and function of lipoproteins were studied in SR-B1(P297S) heterozygotes.Lipoproteins from six SR-B1(P297S) carriers and six family controls were investigated. HDL and LDL/VLDL were isolated by ultracentrifugation and proteins were separated by two-dimensional gel electrophoresis and identified by mass spectrometry. HDL antioxidant properties, paraoxonase 1 activities, apoA-I methionine oxidations and HDL cholesterol efflux capacity were assessed.Multivariate modeling separated carriers from controls based on lipoprotein composition. Protein analyses showed a significant enrichment of apoE in LDL/VLDL and of apoL-1 in HDL from heterozygotes compared to controls. The relative distribution of plasma apoE was increased in LDL and in lipid-free form. There were no significant differences in paraoxonase 1 activities, HDL antioxidant properties or HDL cholesterol efflux capacity but heterozygotes showed a significant increase of oxidized methionines in apoA-I.The SR-B1(P297S) mutation affects both HDL and LDL/VLDL protein compositions. The increase of apoE in carriers suggests a compensatory mechanism for attenuated SR-B1 mediated cholesterol uptake by HDL. Increased methionine oxidation may affect HDL function by reducing apoA-I binding to its targets. The results illustrate the complexity of lipoprotein metabolism that has to be taken into account in future therapeutic strategies aiming at targeting SR-B1.Copyright © 2015 Elsevier B.V. All rights reserved.
Related Compounds
Related Articles:
Structure and boosting activity of a starch-degrading lytic polysaccharide monooxygenase.
2015-01-01
[Nat. Commun. 6 , 5961, (2015)]
Antimicrobial activity of natural products from the flora of Northern Ontario, Canada.
2015-06-01
[Pharm. Biol. 53(6) , 800-6, (2015)]
2015-07-07
[Anal. Chem. 87 , 6966-73, (2015)]
Design and Evaluation of Tumor-Specific Dendrimer Epigenetic Therapeutics.
2015-06-01
[ChemistryOpen 4 , 335-41, (2015)]
Proteomics profiling of ethylene-induced tomato flower pedicel abscission.
2015-05-21
[J. Proteomics 121 , 67-87, (2015)]